Catalyst Health Solutions, Inc. (CHSI) is gaining 35 percent to $86.00. The company and SXC Health Solutions (SXCI, SXC.TO) would combine in a cash and stock transaction valued at about $4.4 billion. Catalyst shareholders will receive $28.00 cash and 0.6606 SXC shares for each Catalyst share, implying a purchase price of $81.02 per Catalyst share. SXCI is rising 16 percent to $92.92.
Abbott Laboratories (ABT) is rising 1 percent to $61.22. The company's first quarter earnings and sales grew from the previous year period and were above Wall Street view. In addition, the company raised its full-year 2012 ongoing earnings per share guidance.
Halliburton Co. (HAL) is up over 2 percent to $33.40. The company's profit increased from the previous year. consolidated revenue improved 30 percent from the year-ago quarter and were above consensus.
Textron Inc. (TXT) is up 1 percent to $28.01. The company's first quarter profit increased from the year-ago quarter and revenues rose 15.2 percent. Both earnings per share revenues were above analysts' estimates. Meanwhile, the company confirmed its guidance of 2012.
Yahoo! Inc. (YHOO) is up 3 percent to $15.47 as the company's first quarter profit and revenues increased from the previous year and also topped Wall Street view. The company guided second quarter revenues, excluding traffic acquisition costs, in-line with analysts' estimate.
Pfizer Inc. (PFE) is down 0.45 percent to $22.21. The company is reportedly close to selling its infant-nutrition business to Nestlé SA (NSRGY.PK) for at least $9 billion.
Cree, Inc. (CREE) is down over 5 percent to $30.16 as the company's third quarter profit plunged from the year-ago quarter. Non-GAAP earnings per share were below Wall Street view by a penny. Revenue rose 30 percent, but were below consensus. In addition, the company expects its fourth quarter results below analysts' expectations.
International Business Machines Corp. (IBM) is falling 2 percent to $203. The company's first quarter profit increased from the previous year and operating earnings per share were above Wall Street view. However, revenues fell short of analysts' estimate. Meanwhile, the company raised its full-year 2012 operating earnings guidance.
Intel Corp. (INTC) is down over 2 percent to $27.70. The company's first quarter profit declined from the year-ago quarter, but were above consensus. Net revenue increased from the prior year and also were above consensus.
by RTT Staff Writer
For comments and feedback: email@example.com